Prime Medicine, Inc. Common Stock (PRME) — Financial Flexibility Index
Prime Medicine, Inc. Common Stock (PRME) has a Financial Flexibility Index of -0.19x as of March 2026. Free cash flow of $-42.50 Million (operating CF $-42.71 Million minus capex $214.00K) represents 0% of total liabilities ($218.03 Million). Check Prime Medicine, Inc. Common Stock strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Prime Medicine, Inc. Common Stock Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Prime Medicine, Inc. Common Stock across 7 annual periods. See Prime Medicine, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Prime Medicine, Inc. Common Stock (2019–2025)
Year-by-year free cash flow to debt coverage for Prime Medicine, Inc. Common Stock. For the full company profile including market capitalisation, see Prime Medicine, Inc. Common Stock (PRME) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.71x | $-158.03 Million | $-162.56 Million | $221.87 Million | ▲ +11.0% |
| 2024 | -0.80x | $-115.57 Million | $-122.86 Million | $144.36 Million | ▲ +68.9% |
| 2023 | -2.58x | $-156.69 Million | $-165.41 Million | $60.78 Million | ▲ +1.9% |
| 2022 | -2.63x | $-115.73 Million | $-131.83 Million | $44.04 Million | ▼ -446.9% |
| 2021 | -0.48x | $-29.93 Million | $-34.08 Million | $62.30 Million | ▼ -108.7% |
| 2020 | -0.23x | $-4.91 Million | $-5.54 Million | $21.31 Million | ▼ -142.0% |
| 2019 | -0.10x | $-695.00K | $-1.33 Million | $7.31 Million | — |